Biosensor technology in the treatment of cardiovascular disease - Biomaterials and Devices for the Circulatory System - page 299

22. SHERR J, CENGIZ E, TAMBORLANE WV. From pumps to prevention: recent
advances in the treatment of type 1 diabetes. Drug Discovery Today 2009;
14 (19/20):973-981.
23. LUSIS AJ. Atherosclerosis: review article. Natur e 2000; 407 :233-241.
24. NAPOLI C, LERMAN LO, SICA V, LERMAN A, TAJANA G, DE NIGRIS F. Microarray analy-
sis: a novel research tool for cardiovascular scientists and physicians. Heart 2003;
89 :597-604.
25. OKUDA T, SUMIYA T, IWAI N, MIYATA T. Difference of gene expression profi les in
spontaneous hypertensive rats and Wistar-Kyoto rats from two sources. Bio-
chemical and Biophysical Research Communications 2002; 296 :537-543.
26. STANTON LW , GARRARD LJ, DAMM D, GARRICK BL, LAM A, KAPOUN AM, ZHENG Q,
PROTTER AA, SCHREINER GF, WHITE RT. Altered patterns of gene expression in
response to myocardial infarction. Circulation Research 2000; 86 :939-945.
27. BARRANS JD, STAMATIOU D, LIEW CC. Construction of a human cardiovascular
cDNA microarray: portrait of the failing heart. Biochemical and Biophysical
Research Communications 2001; 280 :964-969.
28. HEALY AM, PICKARD MD, PRADHAN AD, WANG Y, CHEN Z, CRO CE K, SAKUMA M, SHI
C, ZAGO AC, GARASIC J, DAMOKOSH AI, DOWIE TL, POISSON L, LILLIE J, LIBBY P, RIDKER
PM, SIMON DI. Platelet expression profi ling and clinical validation of myeloid-
related protein-14 as a novel determinant of cardiovascular events. Circulation
2006; 113 :2278-2284.
29. GUL O, CALAY E, SEZERMAN U, BASAGA H, GURBUZ Y. Sandwich-type, antibody
microarrays for the detection and quantifi cation of cardiovascular risk markers.
Sensors and Actuators B 2007; 125 :581-588.
30. GANTER M & ZOLLINGER A. Continuous intravascular blood gas monitoring:
development, current techniques and clinical use of a commercial device. British
Journal of Anaesthesia 2003; 91 (3):397-407.
31. CHAVEZ JJ, WEATHERALL JS, STREVELS SM, LIU F, SNIDER CC, CARROLL RC.
Evaluation of a point-of-care coagulation analyzer on patients undergoing
cardiopulmonary bypass surgery. Journal of Clinical Anesthesia 2004;
16 :7-10.
32. CONNOLLY P. The potential for biosensors in cardiac surgery. Perfusion 2004;
19 :247-249.
33. PAPARELLA D, YAU TM, YOUNG E. Cardiopulmonary bypass induced infl ammation:
pathophysiology and treatment. An update. European Journal of Cardio-
thoracic Surgery 2002; 21 :232-244.
34. BASHIR R. BioMEMS: state-of-the-art in detection, opportunities and prospects.
Advanced Drug Delivery Reviews 2004; 56 :1565-1586.
35. WEIGL BH, BARDELL RL, CABRERA CR. Lab-on-a-chip for drug development.
Advanced Drug Delivery Reviews 2003; 55 :349-377.
36. JAIN KK. Post-genomic applications of lab-on-a-chip and microarrays. Trends in
Biotechnology 2002; 20 (5):184-185.
37. JOHNSON RD, GAVALAS VG, DAUNERT S, BACHAS LG. Microfl uidic ion-sensing
devices. Analytica Chimica Acta 2008; 613 :20-30.
38. VADGAMA P. Microfl uidic assays in practice. Nanotoday 2006; 1 (3 ):56.

￿ ￿ ￿ ￿ ￿